LifeMD announced significant enhancements to its weight management program, underscoring the company’s commitment to expanding patient access and improving the quality and comprehensiveness of care available on its virtual care platform. The investments include a new and improved platform and partnership for in-home lab collection, technology enhancements for prior authorization and pharmacy benefits infrastructure, and the launch of personalized prescription treatment options. These advancements further establish LifeMD as a leader in the rapidly growing market for virtual healthcare.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LFMD:
- LifeMD to Participate in Three Investor Conferences During September
- LifeMD shares ‘significantly undervalued’ versus peers, says B. Riley
- LifeMD price target lowered to $12 from $14 at BTIG
- LifeMD backs FY24 revenue at least $205M, consensus $206M
- LifeMD sees Q3 revenue $53M-$54M, consensus $53.27M